Simbec-Orion

Simbec-Orion is a well-established player in the Biotechnology and Pharmaceutical sectors, founded in 1997 and headquartered in the United Kingdom. The company specializes in delivering flexible, high-quality Phase I-IV clinical trial solutions, underscored by their commitment to integrity, as captured in their slogan: "Flexible, high-quality, Phase I - IV clinical trial solutions, delivered with integrity."

With almost five decades of experience, Simbec-Orion offers a comprehensive range of clinical trial services, from First-in-Human studies to Phase III and post-marketing trials. Their unique positioning as a global, full-service CRO gives them the edge to provide tailor-made clinical development solutions, particularly suited for small and mid-size drug developers. Their expertise spans clinical pharmacology, oncology, and rare diseases.

For investors, Simbec-Orion's adaptability, specialist expertise, and long-standing industry presence make it a strategically sound investment opportunity aimed at accelerating the development of innovative medicines.